Same‐day fluorescence confocal microscopy of <scp>MRI</scp> ‐targeted prostate biopsies: A feasibility study
Ex vivo FCM provides rapid, accurate, and reproducible assessment of MRI-targeted prostate biopsy specimens for cancer detection within clinically feasible timeframes. These findings support FCM as a same-day diagnostic adjunct and justify prospective trials evaluating real-time implementation during targeted biopsy.
Authors
- Zeyad Schwen (ORCID: https://orcid.org/0000-0001-7334-3600)
- Nicolas Soputro (ORCID: https://orcid.org/0000-0002-5419-0327)
- Karim Daher
- Samarpit Rai
- Salim K. Younis
- Rui Bernardino
- Mohamad Watfa
- Abdulrahman Al‐Bayati
- Jane K. Nguyen
- Ruben Olivares
- Christopher J. Weight
- Jihad Kaouk
- Riccardo Autorino
- Lin Wang
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2026-03-28
- DOI
- https://doi.org/10.1111/bju.70263
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00